Archives stem-cells

by in
Entry Author Date Location
Novelos Cancer Drug to Enter Phase II With $4M Investment 02/06/14 Wisconsin
Ann Arbor’s 3D Biomatrix Clears Final Hurdle to Patent 02/06/14 Detroit
$40M Establishes New Center for Stem Cell Genomics in Bay Area, SD 01/29/14 San Diego
Texas Biotech Leaders Doubt CPRIT Will Get Its Groove Back 01/24/14 Texas
EPA Taps Stemina to Screen Drugs for Possible Birth Defects 01/09/14 Wisconsin
Stem Cell Maker Cellular Dynamics Strikes Deal With Nestle 01/08/14 Wisconsin
Stem Cells, Inc. Expanding Trial in Age-Related Eye Affliction 12/18/13 San Francisco
San Diego Life Sciences Roundup: Santarus, Cytori, IPOs, and More 11/08/13 San Diego
An Insider’s Antidote for Dangerous Stem Cell Hype 10/22/13 San Francisco
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More 08/15/13 San Diego
Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M 08/14/13 San Diego
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
SMC Bio Looks to Heal Bones With Carbohydrates, Not Stem Cells 07/18/13 San Francisco
Cellular Dynamics, Coriell To Create California Stem Cell Bank 06/17/13 San Francisco
Verastem Switches CEOs as Westphal Steps Into Chairman Role 06/06/13 Boston
Histogen Forms Joint Venture to Advance Regenerative Orthopedics 03/11/13 San Diego
California Stem Cell Agency Shifts Focus to Clinical Treatments 01/31/13 San Francisco
The Fiscal Cliff Is Forcing a Biomedical Day of Reckoning 12/31/12 National
Geron Pinning Hopes On Single Drug Platform 12/19/12 San Francisco
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
ViaCyte CEO Says $10M Grant Will Move Stem Cell Therapy to Trial 10/30/12 San Diego
Translating Nobel Science Into Novel Drugs 10/12/12 San Francisco
San Diego Life Sciences Roundup: Optimer, CareFusion, Senomyx & More 10/11/12 San Diego
San Diego Life Sciences Roundup: Santarus, Shire, Illumina, & More 09/06/12 San Diego
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
SD at Center of Shire’s Plan for Regenerative Medicine Business 06/14/12 San Diego
Xconomist of the Week: Evan Snyder—Stem Cell Reality Check 05/25/12 San Diego
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration 05/21/12 San Francisco
Progress for Pervasis and InVivo: A Boost for Regenerative Efforts? 04/19/12 Boston
Page 2 of 7 « previous page · next page »